Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 8 months ago

Possible Interaction: Fenofibrate and Asymmetric Dimethylarginine

Research Papers that Mention the Interaction

8-week treatment with fenofibrate significantly reduced the elevated levels of ADMA (0.53±0.12 μmol/L, P<0.01), MDA and TNF-α, attenuated the decreased level of NO and improved endothelial function.
European Journal of Clinical Pharmacology  •  2005  |  View Paper
fenofibrate (… ADMA , LDH and TNF-α, attenuated the decreased levels of NO and the decreased activity of DDAH and prevented the activation of NF-κB. Similar …. The beneficial effects of fenofibrate on cultured endothelial cells were abolished by MK-886, a specific peroxisome proliferator-activated receptor-α (PPARα) antagonist.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2005  |  View Paper
Treatment with fenofibrate (30 or 100 mg/kg) significantly reduced the inhibition of vasodilator responses to acetylcholine, decreased the elevated levels of ADMA , MDA and TNF-α, and enhanced the decreased level of nitrite/nitrate in the rats treated with LDL.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper